The Essential Elements of Local Public Health provides updates and information from NACCHO’s Environmental Health and Infectious Disease portfolios.
National Black HIV/AIDS Awareness Day (NBHAAD), observed annually on February 7, is a chance to get more involved in getting the word...
Feb 04, 2021 | Julia Zigman
NASTAD’s FAQ provides current information on the introduction of PrEP generics, potential coverage changes related to the changing...
Jan 22, 2021 | Julia Zigman
NACCHO will fund up to 4 local health departments (LHDs) up to $100,000 each to implement pharyngeal gonorrhea test of cure. This...
Jan 19, 2021 | Rebekah Horowitz
A paper today in Morbidity and Mortality Weekly Reports (MMWR) describes the first US case of Neisseria gonorrhoeae harboring a...
Dec 17, 2020 | Julia Zigman
The recently FDA-authorized Pfizer-BioNTech COVID-19 vaccine is not contraindicated for people living with HIV or others with...
CDC has updated its gonorrhea treatment guidelines to recommend treating infections with a single, higher dosage injection of...
Dec 17, 2020 | Shalesha Majors
Dec 14, 2020
On December 1 the CDC Advisory Committee on Immunization Practices (ACIP) voted on recommendations as to who should be first to...
Dec 04, 2020 | Lynda Neal
The CDC published a study in the Morbidity and Mortality Weekly Report that found that the age-adjusted rate of HIV-related deaths...
Dec 03, 2020 | Shalesha Majors
National Black HIV/AIDS Awareness Day (NBHAAD), observed annually on February 7, is a chance to get more involved in getting the word out that HIV is preventable and treatable.
NASTAD’s FAQ provides current information on the introduction of PrEP generics, potential coverage changes related to the changing PrEP drug market, and the impact on PrEP access.
NACCHO will fund up to 4 local health departments (LHDs) up to $100,000 each to implement pharyngeal gonorrhea test of cure. This implementation will provide essential information about the feasibility of implementing TOC for all pharyngeal gonorrhea cases in clinical practice.
A paper today in Morbidity and Mortality Weekly Reports (MMWR) describes the first US case of Neisseria gonorrhoeae harboring a genetic element that confers resistance to a first-line antibiotic.
The recently FDA-authorized Pfizer-BioNTech COVID-19 vaccine is not contraindicated for people living with HIV or others with immunocompromised conditions.
CDC has updated its gonorrhea treatment guidelines to recommend treating infections with a single, higher dosage injection of ceftriaxone. A two-drug approach is no longer recommended.
On December 1 the CDC Advisory Committee on Immunization Practices (ACIP) voted on recommendations as to who should be first to receive COVID-19 vaccinations.
The CDC published a study in the Morbidity and Mortality Weekly Report that found that the age-adjusted rate of HIV-related deaths among people with HIV in the U.S. fell by nearly half from 2010 to 2017.
Create an account or login to MyNACCHO and go to "My Subscriptions."
Calendar
The largest convening of local health department leaders and public health professionals in the United States.
Register
NACCHO, with support from the Centers for Disease Control and Prevention (CDC), released a funding opportunity for The Improving...
Feb 12, 2024 | Tori Decea
The EPA's Small Communities, Big Challenges Competition encourages local governments to demonstrate their innovative strategies, from...
Nov 16, 2023 | Anu Varma
Celebrate with us!
Oct 12, 2023 | Anu Varma
Sep 11, 2023 | Irene Halferty, Kristen Ross
Sep 08, 2023 | Irene Halferty, Kristen Ross
The Building Local Operational Capacity for COVID-19, Healthcare-Associated Infections, and Antimicrobial Resistance (BLOC COVID-19+)...
Aug 14, 2023 | Irene Halferty, Kristen Ross
The Preparedness Brief provides updates and information from NACCHO’s public health preparedness portfolio.
This blog embodies NACCHO's mission to empower local health departments and drive positive change.
Stories from the Field provides a means for local health departments to share their experiences and demonstrate the value of public health.
The NACCHO website uses cookies to offer our visitors a better browsing experience, to analyze our website traffic, and to present personalized content; cookies are small data files that are attached to your computer when you visit websites. You can read about how we use cookies by clicking on the "details" button below. If you continue to use this website, you are consenting to our use of cookies.